Relevant bibliographies by topics / DVT Prophylaxis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'DVT Prophylaxis'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'DVT Prophylaxis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "DVT Prophylaxis"

1

Deng, Jing, Lisa Thomas, Huijing Li, et al. "Overuse of DVT Prophylaxis in Medical Inpatients." Blood 126, no. 23 (2015): 5563. http://dx.doi.org/10.1182/blood.v126.23.5563.5563.

Full text
Abstract:
Abstract Introduction: Unfractionated heparin (UFH), or low-molecular-weight heparin (LMWH), is commonly used with mechanical prophylaxis as an anticoagulant to reduce the risk for venous thromboembolism (VTE). However, overuse of these prophylaxes can increase the risk of bleeding, heparin-induced thrombocytopenia (HIT) and associated medical cost. PURPOSE: The aim of this study is to determine the incidence of DVT prophylaxis among hospitalized nonsurgical patients in a community medical center. To evaluate the use of the prophylaxes as described above, the investigators collected data on me
APA, Harvard, Vancouver, ISO, and other styles
2

SHEIKH, MUHAMMAD SAJID, and MUHAMMAD FASIH UR REHMAN. "DVT PROPHYLAXIS." Professional Medical Journal 18, no. 02 (2011): 275–79. http://dx.doi.org/10.29309/tpmj/2011.18.02.2080.

Full text
Abstract:
Objectives: To evaluate the effectiveness of LMWH prophylaxis for DVT in high risk patients after general surgery. Study design: Randomized controlled study. Setting: Surgical Unit-IV, District Head Quarters Hospital, Faisalabad. Period: From March 2009 to August 2009. Patients and Methods: Sixty patients in the LMWH group were given perioperative enoxaparin (Clexane) as prophylaxis while compression stockings were used in another control group comprised of 60 patients. At 5th postoperative day, Doppler study was performed to detect DVT in both groups. Categorical data were analyzed for signif
APA, Harvard, Vancouver, ISO, and other styles
3

Sarker, A., D. Yelle, K. Wooller, and E. M. Kelly. "A153 INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) & PROPHYLAXIS PRACTICES IN DECOMPENSATED CIRRHOSIS INPATIENTS." Journal of the Canadian Association of Gastroenterology 3, Supplement_1 (2020): 17–18. http://dx.doi.org/10.1093/jcag/gwz047.152.

Full text
Abstract:
Abstract Background The coagulation cascade is disturbed in cirrhosis. Patients are at risk for bleeding and coagulation through an imbalance of pro and anticoagulant factors. Aims We evaluated the incidence of DVTs and prevalence of DVT prophylaxis in hospitalized patients with decompensated cirrhosis. Methods A retrospective study of decompensated cirrhotic patients admitted to a tertiary care hospital. We evaluated the incidence of DVTs and use of DVT prophylaxis in this cohort. We also evaluated differences in patient characteristics in those who received DVT prophylaxis and between patien
APA, Harvard, Vancouver, ISO, and other styles
4

Ah-See, K. W., J. Kerr, and D. W. Sim. "Prophylaxis for venous thromboembolism in head and neck surgery: the practice of otolaryngologists." Journal of Laryngology & Otology 111, no. 9 (1997): 845–49. http://dx.doi.org/10.1017/s0022215100138770.

Full text
Abstract:
AbstractDeep venous thrombosis (DVT) and pulmonary embolism (PE) are an important cause of morbidity and mortality in the surgical patient. The first guideline produced by the Scottish Intercollegiate Guidelines Network was for the prophylaxis of venous thromboembolism. Patients undergoing major head and neck cancer surgery commonly exhibit risk factors for venous thromboembolism. Currently, however, there are no data on its incidence in these patients. A questionnaire survey was performed to assess the current practice of consultant otolaryngologists regarding DVT prophylaxis in patients unde
APA, Harvard, Vancouver, ISO, and other styles
5

Lin, Feng-Fei, Chao-Hui Lin, Bin Chen, and Ke Zheng. "Combination Prophylaxis versus Pharmacologic Prophylaxis Alone for Preventing Deep Vein Thrombosis in Hip Surgery." HIP International 26, no. 6 (2016): 561–66. http://dx.doi.org/10.5301/hipint.5000384.

Full text
Abstract:
Purpose To evaluate the comparative efficacy and safety of combination pharmacologic and graduated compression stockings (GCS) prophylaxis versus pharmacological prophylaxis alone for preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in hip surgery. Methods Relevant publications indexed in PubMed, Cochrane Library, Embase, Web of Science, Wanfang Data, CNKI and Sinomed (CBM) were identified. Appropriate articles identified from the reference lists of the above searches were also reviewed. Results Significant differences in the rate of distal DVT were observed between combinatio
APA, Harvard, Vancouver, ISO, and other styles
6

Cheng, Gregory, Crystal Chan, Ying Ting Liu, et al. "Incidence of Deep Vein Thrombosis in Hospitalized Chinese Medical Patients and the Impact of DVT Prophylaxis." Thrombosis 2011 (February 15, 2011): 1–4. http://dx.doi.org/10.1155/2011/629383.

Full text
Abstract:
Objective. To evaluate the incidence of deep vein thrombosis in hospitalized Chinese medical patients and the impact of DVT prophylaxis. Methods. All cases of confirmed proximal DVT from 1 January 2005 to 31 December 2008 were reviewed retrospectively to determine the presence of risk factors and whether DVT developed: during hospitalization in medical wards or in case of readmission with a diagnosis of DVT within 14 days of discharge from a recent admission to medical wards. The impact of prophylaxis will be estimated by comparing the annual incidence of proximal DVT among medical patients ho
APA, Harvard, Vancouver, ISO, and other styles
7

Shirol, S. S., Srinivas Kodaganur, M. Raghavendra Rao, and Vinaykumar Tiwari. "The conundrum of deep vein thrombosis prophylaxis in burns in India and review of literature." Indian Journal of Plastic Surgery 50, no. 03 (2017): 288–94. http://dx.doi.org/10.4103/ijps.ijps_179_15.

Full text
Abstract:
ABSTRACTObjective: The aim is to assess the practice of deep vein thrombosis (DVT) prophylaxis among the plastic surgeons attending National Academy of Burns India Conference 2012 (NABICON 2012). Background: DVT prophylaxis in burns is a controversial issue as there is no consensus among the community of burn surgeons about the prevalence of DVT, the incidence of pulmonary embolism, the indications for DVT prophylaxis, dosage and duration of low molecular weight heparins (LMWH) and the complications related to DVT and LMWH. Methodology: A survey was conducted among plastic surgeons attending t
APA, Harvard, Vancouver, ISO, and other styles
8

Wido, Akbar, Abdul Hafid Bajamal, Tedy Apriawan, Muhammad Arifin Parenrengi, and Asra Al Fauzi. "Deep vein thrombosis prophylaxis use in traumatic brain injury patients in tropical climate." International journal of health & medical sciences 5, no. 1 (2022): 67–74. http://dx.doi.org/10.21744/ijhms.v5n1.1840.

Full text
Abstract:
Deep Vein Trombosis (DVT) is one of the extracranial complications after TBI. Prophylaxis DVT using on TBI reduce incidence and mortality. Climate variants of an area affect the risk of DVT. UV ray increasing synthesis of vitamin D and lowering risk of thrombus fomation. A systematic review and meta-analysis we performed according PRISMA guidelines. A through literature search was conducted on PubMed, Scopus, and Cochrane database. Total 3 publications match study criteria with 178 samples, without 144 samples and 34 samples with prophylaxis. The overall incidence is 5% (0-6.8%), without 6.25%
APA, Harvard, Vancouver, ISO, and other styles
9

Kukar, Moshim, Joseph Asaro, Anthony Aquino, Adrienne Groman, Joseph Skitzki, and John M. Kane. "Incidence of Venous Thromboembolic Events in Mandated Risk Assessment versus Optional DVT Prophylaxis Era at a Large Tertiary Cancer Center." American Surgeon 81, no. 9 (2015): 893–98. http://dx.doi.org/10.1177/000313481508100924.

Full text
Abstract:
Cancer patients are thought to be at high risk for venous thromboembolic events (DVT/PE). Beginning in October 2007, our tertiary cancer center instituted “mandated risk assessment” computerized DVT prophylaxis order entry, for all hospital admissions with an option for active opt out by the physician with a stated reason. Retrospective review of all DVT/PE events within 30 days of a hospital admission [any inpatient admission (IA) and outpatient surgery (OPS)] in comparable “optional (O)” (January 2005—September 2007) vs “mandated risk assessment (M)” (October 2007–May 2010) DVT prophylaxis o
APA, Harvard, Vancouver, ISO, and other styles
10

Busato, Cesar Roberto, Ricardo Zanetti Gomes, Dieyson Martins de Melo Costa, and Tiago Francisco Meleiro Zubiolo. "Evaluation of thromboprophylaxis in medium-sized general hospital." Jornal Vascular Brasileiro 13, no. 1 (2014): 05–11. http://dx.doi.org/10.1590/jvb.2014.003.

Full text
Abstract:
CONTEXT: Deep vein thrombosis (DVT) is a serious, common disease whose complications include pulmonary thromboembolism (PTE) and postthrombotic syndrome. The importance and benefits of correct and effective pharmacological prophylaxis for DVT are well documented. OBJECTIVES: The aims of this study were to evaluate adequacy of prophylaxis for DVT and PTE at the Santa Casa de Misericórdia de Ponta Grossa (SCMPG), Paraná, Brazil, and determine risk stratification for patients hospitalized in this institution. METHODS: A cohort study was conducted to assess DVT prophylaxis of patients hospitalized
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "DVT Prophylaxis"

1

Crawford, Yupin. "The cost-effectiveness of current practice of venous thromboembolism prophylaxis as compared to no prophylaxis or pharmaceuticals only prophylaxis." Thesis, Queensland University of Technology, 2018. https://eprints.qut.edu.au/120279/1/Yupin_Crawford_Thesis.pdf.

Full text
Abstract:
This research uses economic evaluation methods to model the current practice of VTE prevention at the Gold Coast Hospital and Health Services compared to historical controls. Additionally the research tested the hypothesis that improved prescribing compliance would achieve better clinical outcomes and would be cost effective. This research revealed that current VTE prophylaxis practice were cost effective as compared to either no or suboptimal prevention. Economic modeling revealed that increasing prescribing compliance to 95% to achieve a lower incidence of DVT and PE was cost effective for G
APA, Harvard, Vancouver, ISO, and other styles
2

Bergström, Joakim. "A Search for the Masked Mechanism Behind IgG-Mediated Suppression of Antibody Responses." Doctoral thesis, Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-317480.

Full text
Abstract:
Antibodies passively administered together with their specific antigen can enhance or suppress the specific antibody response. This phenomenon is known as antibody feedback regulation. Whether this modulation causes up- or downregulation of the antibody response depends both on the antibody isotype and the antigen used. IgG antibodies passively administered together with particulate antigens, e.g. erythrocytes, can completely prevent the induction of an antibody response to the antigen. The suppressive capacity of IgG has been routinely used in the clinic since the 1960’s in RhD-prophylaxis to
APA, Harvard, Vancouver, ISO, and other styles
3

Gaston, Sherryl. "Venous thromboembolism (VTE) risk assessment and prophylaxis: a comprehensive systematic review of the facilitators and barriers to healthcare worker compliance with clinical practice guidelines in the acute care setting." Thesis, 2013. http://hdl.handle.net/2440/82715.

Full text
Abstract:
Background: Even though guidelines for venous thromboembolism (VTE) risk assessment and prophylaxis are available, patients with identifiable risk factors admitted to acute hospitals are not receiving appropriate prophylaxis. The incidence of VTE in hospitalised patients is higher than that of people living in the community who have similar demographics. Knowledge of barriers to clinician compliance with clinical practice guidelines and facilitators to improve compliance will aid appropriate use of VTE clinical practice guidelines. Objectives: The objective of this review was to identify the b
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "DVT Prophylaxis"

1

Loochtan, Aaron I., Jodi Dodds, and Cheryl D. Bushnell. Hemorrhagic Stroke Management in Pregnancy. Edited by Emma Ciafaloni, Cheryl Bushnell, and Loralei L. Thornburg. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190667351.003.0015.

Full text
Abstract:
Intracerebral hemorrhage (ICH) during pregnancy and the puerperuim is a rare but potentially devastating complication of pregnancy. It is a condition that requires emergent medical attention and inclusion of multiple medical and or surgical specialists. Accurate diagnosis based on clinical exam and supported by neuroimaging techniques is essential. Medical management is the mainstay in most cases including post-hemorrhage blood product consideration, reversal agents if on anti-coagulation, blood pressure control, cerebral edema management, and treatment of seizures. Circumstances also arise in
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "DVT Prophylaxis"

1

Sheng, Neha. "DVT Prophylaxis." In Common Surgical Diseases. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1565-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Perinpanayagam, Gajen. "DVT Prophylaxis." In Hot Topics in Acute Care Surgery and Trauma. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-68099-2_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ray, M. D. "DVT: Prophylaxis and Management." In Multidisciplinary Approach to Surgical Oncology Patients. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-7699-7_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Baldwin, Keith D., Surena Namdari, and Samir Mehta. "DVT Prophylaxis in Orthopedic Trauma." In Orthopedic Traumatology. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3511-2_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baldwin, Keith D., Surena Namdari, Jeffrey Zhao, and Samir Mehta. "DVT Prophylaxis in Orthopedic Trauma." In Orthopedic Traumatology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-73392-0_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Krumme, John, Sanjay Kubsad, and Gregory J. Golladay. "Advances in Pain Management and DVT Prophylaxis." In Surgical Management of Knee Arthritis. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-47929-8_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Molliqaj, Granit, Matthias Robin, Christoph Czarnetzki, Marie-Josée Daly, Americo Agostinho, and Enrico Tessitore. "Perioperative Management: Surgical Site Infection Prevention, DVT Prophylaxis, and Blood Loss Management." In Surgery of the Cranio-Vertebral Junction. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18700-2_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"DVT prophylaxis." In Practical Phlebology. CRC Press, 2013. http://dx.doi.org/10.1201/b16011-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lamsal, Ritesh, and Navindra R. Bista. "DVT prophylaxis." In Essentials of Evidence-Based Practice of Neuroanesthesia and Neurocritical Care. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-12-821776-4.00025-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Campbell, Bruce. "Prophylaxis of venous thromboembolism." In Perioperative Medicine. Oxford University PressOxford, 2006. http://dx.doi.org/10.1093/oso/9780199211739.003.0013.

Full text
Abstract:
Abstract Venous thromboembolism is a major cause of death and morbidity among surgical patients. Most deep vein thromboses (DVTs) produce no clinical signs, and most pulmonary emboli (PE) are caused by clinically silent DVTs. DVT may be followed by troublesome postphlebitic syndrome with leg swelling, lipodermatosclerosis, and ulceration. There is now plentiful evidence from good randomized studies that prophylactic measures are effective in reducing (but not eliminating) the risk of thromboembolism. If a patient at risk develops DVT or PE and demonstrable prophylaxis was not used, then the re
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "DVT Prophylaxis"

1

Green, D., T. Cohn, P. Filbrandt, et al. "THROMBOEMBOLISM PROPHYLAXIS IN SPINAL CORD INJURY: FIXED VS ADJUSTED DOSE HEPARIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643596.

Full text
Abstract:
We had previously estimated the incidence of deep vein thrombosis (DVT) in untreated spinal cord injury patients with complete motor paralysis to be 78% (Paraplegia 20:227, 1982). Therefore, we have begun to randomize patients to receive prophylaxis with either fixed dose heparin (5,000 u every 12 h subcutaneously) or adjusted dose heparin (mean dose, 13,890 u every 12 h). Treatment is started within 72 hrs of injury, and continued for 12 weeks. Nineteen subjects have received the fixed dose for 155 weeks, and 21 the adjusted dose for 153 weeks (p = N.S.). Patients have had daily clinical exam
APA, Harvard, Vancouver, ISO, and other styles
2

Kußmann, J., M. Spannaql, J. Boehnke, H. G. Kückel-haus, and W. Schramm. "LOW DOSE HEPARIN PROPHYLAXIS IN HIP FRACTURE SURGEY -HEPARIN EFFECT; INHIBITORS; FIBRINOLYSIS AND INCIDENCE OF DVT." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644193.

Full text
Abstract:
In a prospective studie 129 patients with hip fracture surgery under LDH-prophylaxis (3x5000 U Na-heparinat) were examined in order to find an answer tothe question, if there is a correlation between inhibitor activity, parameters of fibrinolysis, plasma heparin activity and the incidence of DVT.100 patients with ascending phlebography on day 7 to9 post op. were taken into final consideration (blood collection on admission and on day 1, 2, 4, 7 after surgery):1)Incidence of DVT : 17 %.2)Inhibitors: No difference between patients with and without DVT with respect to AT III activity and prot. C
APA, Harvard, Vancouver, ISO, and other styles
3

Stewart, G. J., J. W. Lachman, P. D. Alburger, M. C. Ziskin, C. M. Philips, and K. Jensen. "VENODILATION AND DEVELOPMENT OF DEEP VEIN THROMBOSIS IN TOTAL HIP AND KNEE REPLACEMENT PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643696.

Full text
Abstract:
Postoperative deep vein thromboisis(DVT) is a frequent complication following total hip (THR) or knee (TKR)replacement but no test has been devised to identify specific patientswho will develop DVT. Because conventional prophylaxis does not significantly reduce the incidence of DVT, monitoring is widely used to detect evolving thrombosis. More intense anticoagulation (adjusted dose heparin,two step warfarin) may be effective but requires laboratory tests and carries increased risk of bleeding. Itwould be an economic and medical advantage to restrict prophylaxis and monitoring to patients who w
APA, Harvard, Vancouver, ISO, and other styles
4

Rocha, E., J. A. Práamo, M. J. Alfaro, B. Cuesta, J. Fernádez, and M. Herández. "PREOPERATIVE IDENTIFICATION OF PATIENTS AT HIGH RISK OF DEEP VENOUS THROMBOSIS DESPITE PROPHYLAXIS IN TOTAL HIP REPLACEMENT." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643693.

Full text
Abstract:
Preoperative prediction of postoperativevenous thrombosis was investigated in 111 patients undergoing total hip replacement prophylactically treated with aspirin (1 g/d) or a combination of heparin (5000 IU) plus dihydroergotamine (0.5 mg) twice a day during 7 days. The followingpreoperative parameters were determined:age, sex, overweight percentage, previous thromboembolism, varicose veins,heartdisease, malignancy, plateletcount, platelet-crit, mean platelet volume, circulating platelet aggregates, platelet factor 4, β-thromboglobulin, fibrinogen, Factor Xa, VIII:C, AT III, fibrin monomers, F
APA, Harvard, Vancouver, ISO, and other styles
5

Chayen, D., S. D. Blair, C. N. McCollum, and R. M. Greenhalgh. "PREDICTION OF POST-OPERATIVE DVT BY SALINE DILUTION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644202.

Full text
Abstract:
Clinically, it is difficult to predict deep vein thrombosis (DVT), but the in vitro saline dilution test using the Thrombo-elastograph (TEG) is reported to identify the risk for individual patients [1]. The Biobridge Impedance Clotting Time (ICT) is more sensitive and reproducible than the TEG [2], and we therefore studied 33 patients undergoing elective laparotomy to see if pre-operative saline dilution tests using both the TEG and ICT predicted post-operative DVTs. Post-operatively, both legs were scanned daily for 7 days using 125I Fibrinogen to detect DVTs.The mean age of the patients was
APA, Harvard, Vancouver, ISO, and other styles
6

Yousef, I., M. Zheng, S. Sehgal, A. J. Mamary, and P. Rali. "Impact of DVT Prophylaxis Interruption on VTE Incidence Post Lung Transplant." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bergqvist, D., J. Frisel, T. Hallböök, et al. "PROPHYLAXIS AGAINST POSTOPERATIVE DEEP VEIN THROMBOSIS (DVT)- A DOUBLE-BLIND MULTICENTER TRIAL COMPARING A HEPARIN FRAGMENT GIVEN ON THE EVENING BEFORE SURGERY WITH CONVENTIONAL LOW DOSE HEPARIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644192.

Full text
Abstract:
Bergen, Halmstad, Goteborg and KabiVitrum AB Stockholm, Sweden and Norway. At the Xth Int. Congress on Thrombosis and Haemostasis in San Diego results from a multicenter trial on 432 patients were presented, comparing a low molecular weight heparin (LMWH) fragment (Fragmin, Kabi) once daily with low dose heparin twice daily. Prophylaxis started 2 hours preoperatively. The frequency of postoperative DVT did notdiffer (6.4 % v. 4.3 %) but the onset of thrombosis was delayed in the LMWH group. Haemorrhagic complications occurred significantly more often in the LMWH group (11.6 % v. 4.6 ?o). The r
APA, Harvard, Vancouver, ISO, and other styles
8

LE BALC’H, T., a. LANDAIS, T. BUTEL, D. WEILL, J. C. PASCARIELLO, and A. PLANES. "ENOXAPARINE (LOVENOXR), VERSUS STANDARD HEPARIN IN PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) AFTER TOTAL HIP REPLACEMENT (THR)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643691.

Full text
Abstract:
THR is associated with a high risk of thromboembolic complications. Enoxaparine, LovenoxR, a low-molecular-weight-heparin, and standard heparin were compared in their abilities to prevent DVT in patients undergoing THR. The efficiency and the bleeding risk of each treatment were studied.237 patients, with a non traumatic hip disease, requiringTHR, were included in a multicentric, randomized, double blind trial. Mean age:65.8 years ± 9.2; mean weight :67.3kg ± 1.3.113 patients received standard heparin, 5000 UI/8 hrs, by"subcutaneous (SC) injection. 124 patients received Enoxaparine, 40 mg/24 h
APA, Harvard, Vancouver, ISO, and other styles
9

Briel, R. C., P. C. Hermann, and P. Doller. "LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) PROPHYLAXIS IN GYNECOLOGIC SURGERY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643223.

Full text
Abstract:
In a prospective, randomized study patients undergoing hysterectomy were treated either by the low molecular weight heparin Fragmin or by the combination of unfractionated sodium heparin + dihydroergotamin (HDHE). The dosage in the Fragmin group was 2× 2500 anti Xa-U on day 1 = day of surgery, from day 2-8: 1× 5000 anti Xa-U, in the HDHE-group from day 1-8: 2× 5000 IU heparin + 0.5 mg DHE. 99 patients were randomly allocated to prophylaxis with Fragmin, 101 to HDHE prophylaxis. 95 and 96 respectively were evaluated, the others excluded for different reasons. The 2 groups were comparable for ge
APA, Harvard, Vancouver, ISO, and other styles
10

Poniewierski, M., M. Barthels, and H. Poliwoda. "THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN MEDICAL PATIENTS: A RANDOMIZED DOUBLE-BLIND TRIAL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643224.

Full text
Abstract:
The safety and efficacy of 2500 anti-Factor Xa U of a low molecular weight heparin (Kabi 2165, Fragmin) subcutaneously once a day, and 5000 IU of standard unfractionated Heparin (KabiVitrum, Stockholm) subcutaneously twice daily as thromboprophylaxis was compared in 200 medical patients in a randomized double blind trial. According to the risk of DVT the patients were stratified before randomization in a high and low risk group. The high risk group consisted of 100 patients mainly with malignant diseases and/or previous history of thromboembolism, the low risk group of 100 patients with mainly
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'DVT Prophylaxis' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography